Johnson & Johnson today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with human ...

EVERSANA  to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...

First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line ...

Protein supplements are wildly popular, but CR’s tests of 23 products found that more than two-thirds of them contain more lead in a single serving than our experts say is safe to have in a ...

Detailed price information for Dare Bioscience Inc (DARE-Q) from The Globe and Mail including charting and trades.

Sex cells made from scratch could revolutionize human reproduction. But researchers are struggling to translate promising ...

A trend that originated from rapper Skrilla's song "Doot Doot (6 7)" has become the latest social media trend used in ...

With a new imaging technique, UC San Francisco scientists discover an ecosystem that determines how eggs mature and ovaries ...

Progesterone, oestrogen and testosterone can be detected in skeletons over 1000 years old, offering a way to identify ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line ...